A high-throughput phenotypic screen combined with an ultra-large-scale deep learning-based virtual screening reveals novel scaffolds of antibacterial compounds
Scalia, G.; Rutherford, S. T.; Lu, Z.; Buchholz, K. R.; Skelton, N.; Chuang, K.; Diamant, N.; Huetter, J.-C.; Luescher, J.; Miu, A.; Blaney, J.; Gendelev, L.; Skippington, E.; Zynda, G.; Dickson, N.; Koziarski, M.; Bengio, Y.; Regev, A.; Tan, M.-W.; Biancalani, T.
Show abstract
The proliferation of multi-drug-resistant bacteria underscores an urgent need for novel antibiotics. Traditional discovery methods face challenges due to limited chemical diversity, high costs, and difficulties in identifying structurally novel compounds. Here, we explore the integration of small molecule high-throughput screening with a deep learning-based virtual screening approach to uncover new antibacterial compounds. Leveraging a diverse library of nearly 2 million small molecules, we conducted comprehensive phenotypic screening against a sensitized Escherichia coli strain that, at a low hit rate, yielded thousands of hits. We trained a deep learning model, GNEprop, to predict antibacterial activity, ensuring robustness through out-of-distribution generalization techniques. Virtual screening of over 1.4 billion compounds identified potential candidates, of which 82 exhibited antibacterial activity, illustrating a 90X improved hit rate over the high-throughput screening experiment GNEprop was trained on. Importantly, a significant portion of these newly identified compounds exhibited high dissimilarity to known antibiotics, indicating promising avenues for further exploration in antibiotic discovery.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Broadly applicable and accurate protein design by integrating structure prediction networks and diffusion generative models 96%
- Structure of Mpro from COVID-19 virus and discovery of its inhibitors 95%
- Crystal structures of the σ2 receptor template large-library docking for selective chemotypes active in vivo 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.